Inflammation associated with lung function abnormalities in COVID-19 survivors

Area of Science:

• Pulmonology
• Immunology
• Infectious Diseases

Background:

• COVID-19 is known to activate inflammatory pathways, potentially leading to organ dysfunction.
• Lung function abnormalities are reported in COVID-19 survivors, but underlying biological mechanisms are not fully understood.

Purpose of the Study:

• To investigate the association between serum inflammatory biomarkers and pulmonary function in individuals recovering from severe COVID-19.

Main Methods:

• Prospective evaluation of patients recovering from severe COVID-19.
• Serum biomarkers were measured during hospitalization (admission, peak, discharge).
• Pulmonary function tests were conducted approximately six weeks post-discharge.

Main Results:

• Patients with restrictive spirometry showed higher peak Neutrophil-to-Lymphocyte ratio (NLR) and C-reactive protein levels.
• Abnormal diffusing capacity correlated with elevated baseline and peak NLR, and peak Troponin-T.
• Multivariable analysis indicated that biomarkers explained only a small portion of the variance in pulmonary function outcomes.

Conclusions:

• Increased levels of inflammatory biomarkers are associated with impaired lung function in COVID-19 survivors.
• Inflammation plays a significant role in the development of post-COVID-19 pulmonary complications.